+44 (0)1223 298875

Anti-Niemann Pick C1 Antibody (FITC)

 
Rabbit polyclonal antibody to Niemann Pick C1 (FITC) from FabGennix (NPC1-FITC).
Overview
Name: Anti-Niemann Pick C1 Antibody (FITC)
Description: Rabbit polyclonal antibody to Niemann Pick C1 (FITC)
Applications: ELISA, IHC, IP, WB
Dilutions: ELISA: 1:4,000; ELISA: 1:4,000; Immunocytochemistry: 1:100; Immunofluorescence: 1:100; Immunohistochemistry: 1:100; Immunoprecipitation: 1:150; Western Blot: 1:500
Reactivity: Human, Mouse, Rat
Immunogen: Synthetic peptide taken within amino acid region 1228-1278 on human Niemann-Pick C1 protein.
Host: Rabbit
Clonality: Polyclonal
Conjugate: FITC
Concentration: 0 .5 µg/µl in antibody stabilization buffer
Storage: -20⁰C for long term storage

Target
Function: Intracellular cholesterol transporter which acts in concert with NPC2 and plays an important role in the egress of cholesterol from the endosomal/lysosomal compartment. Both NPC1 and NPC2 function as the cellular 'tag team duo' (TTD) to catalyze the mobilization of cholesterol within the multivesicular environment of the late endosome (LE) to effect egress through the limiting bilayer of the LE. NPC2 binds unesterified cholesterol that has been released from LDLs in the lumen of the late endosomes/lysosomes and transfers it to the cholesterol-binding pocket of the N-terminal domain of NPC1. Cholesterol binds to NPC1 with the hydroxyl group buried in the binding pocket and is exported from the limiting membrane of late endosomes/ lysosomes to the ER and plasma membrane by an unknown mechanism. Binds oxysterol with higher affinity than cholesterol. May play a role in vesicular trafficking in glia, a process that may be crucial for maintaining the structural and functional integrity of nerve terminals.
Involvement in Disease: Niemann-Pick disease C1: A lysosomal storage disorder that affects the viscera and the central nervous system. It is due to defective intracellular processing and transport of low-density lipoprotein derived cholesterol. It causes accumulation of cholesterol in lysosomes, with delayed induction of cholesterol homeostatic reactions. Niemann-Pick disease type C1 has a highly variable clinical phenotype. Clinical features include variable hepatosplenomegaly and severe progressive neurological dysfunction such as ataxia, dystonia and dementia. The age of onset can vary from infancy to late adulthood. An allelic variant of Niemann-Pick disease type C1 is found in people with Nova Scotia ancestry. Patients with the Nova Scotian clinical variant are less severely affected.
Sequence Similarities: Belongs to the patched family.
Post-Translational Modification: Glycosylated.
Cellular Location: Late endosome membrane. Lysosome membrane.
UniProt: O15118
Synonyms: Niemann Pick C1 protein precursor Antibody
Niemann Pick disease, type C1 Antibody
Niemann-Pick C1 protein Antibody
NPC Antibody
NPC1 Antibody
NPC1_HUMAN Antibody
Information: Target information shown above is from the UniProt Consortium.


Please Note: Anti-Niemann Pick C1 Antibody (FITC) is for research use only. It is not intended for diagnostic of therapeutic use.
Antibodies.com | NPC1-FITC
Size Price Quantity
100µg £429

or
Request a quotation
Contact Us Directly
  • call icon + 44 (0)1223 298 875
  • + 44 (0)1223 281 447
  • email icon info@antibodies.com
Product Quality
  • guarantee icon
  • We promise guaranteed product quality
  • and expert customer service.
Lead Time: Currently 5-6 Days
Shipping Information
  • £20 to United Kingdom
  • £35 to Europe